AGEN Agenus Inc.

-0.09  -3%
Previous Close 2.98
Open 3
Price To Book -2.92
Market Cap 378898643
Shares 131,106,797
Volume 2,284,909
Short Ratio
Av. Daily Volume 2,383,420

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1/2 enrolment to be completed 2019.
AGEN2034 and AGEN1884
Solid tumors
Phase 1 presentation at ASCO 2018. 31% ORR.
AGEN1884 (anti-CTLA-4)
Solid cancers
Approval announced October 20, 2017.
Phase 1 data presented at ESMO October 2018 noted clinical benefit of 3/7 cervical cancer patients.
AGEN2034 (anti-PD-1)
Cervical cancer
Phase 1/2 trial initiation announced November 30, 2016.
Solid tumors - cancer
Phase 1/2 trial commenced June 2016
Solid tumors - cancer

Latest News

  1. Analysis: Positioning to Benefit within Micron Technology, Caterpillar, Agenus, Fossil Group, Marathon Petroleum, and Geo Group — Research Highlights Growth, Revenue, and Consolidated Results
  2. Agenus Launches First Asset-Backed Digital-Security Offering in Healthcare
  3. Agenus to Host Call to Launch First Asset-Backed Digital-Security Offering in Healthcare on February 19, 2019
  4. Why Agenus Inc. Stock Took Flight in January
  5. Gilead (GILD) Q4 Earnings Miss Estimates, Revenues Beat
  6. Will Gilead (GILD) Q4 Earnings Disappoint on Weak HCV Sales?
  7. Atomic Capital Kicks off Investor Forum Announcing Digital Offering for NASDAQ-Traded Biotech Group, Agenus Inc.
  8. Agenus to Launch the First Asset-Backed Digital Security Offering in Healthcare
  9. Agenus Closes $150 Million Immuno-Oncology Transaction with Gilead
  10. Research Report Identifies Conagra Brands, W.R. Grace, International Flavors & Fragrances, Spirit Airlines, Sunstone Hotel Investors, and Agenus with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
  11. Agenus (AGEN) Surges: Stock Moves 9.4% Higher
  12. Why Agenus Stock Is Spiking Today
  13. All the Pre-JPM News Healthcare Investors Need to Know
  14. Are Options Traders Betting on a Big Move in Agenus (AGEN) Stock?
  15. Why Celgene, Agenus, and Incyte Jumped Today
  16. Here's Why Agenus Shares Rose as Much as 13.5% Today
  17. Agenus Awarded Grant to Enable QS-21 Innovations
  18. 3 Biotech Stocks That Are Too Cheap to Ignore
  19. Biotech Stock Roundup: ALXN, ACOR Drugs' Get FDA Nod, AGEN up on GILD Deal
  20. 2 Beaten-Down Biotech Stocks That Look Like Bargains Now